James L Murray

James L Murray

UNVERIFIED PROFILE

Are you James L Murray?   Register this Author

Register author
James L Murray

James L Murray

Publications by authors named "James L Murray"

Are you James L Murray?   Register this Author

63Publications

1275Reads

8Profile Views

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.

Invest New Drugs 2018 12 11;36(6):1103-1109. Epub 2018 Oct 11.

Department of Breast Medical Oncology, Dan L. Duncan Building (CPB5.3542), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0672-z
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0672-zDOI Listing
December 2018

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Invest New Drugs 2018 04 27;36(2):299-306. Epub 2018 Jan 27.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building, CPB5.3542, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0564-2
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0564-2DOI Listing
April 2018

Drug Repurposing: New Treatments for Zika Virus Infection?

Trends Mol Med 2016 Nov 28;22(11):919-921. Epub 2016 Sep 28.

Division of Infectious Disease, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Research Medicine, VA Tennessee Valley Healthcare System, Nashville, TN 37212, USA.

View Article

Download full-text PDF

Source
http://www.cell.com/trends/molecular-medicine/pdf/S1471-4914
Web Search
http://dx.doi.org/10.1016/j.molmed.2016.09.006DOI Listing
November 2016

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis.

PLoS Comput Biol 2016 09 15;12(9):e1005074. Epub 2016 Sep 15.

Division of Infectious Disease, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1005074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025164PMC
September 2016

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.

Clin Breast Cancer 2015 Oct 24;15(5):325-31. Epub 2015 Mar 24.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568133PMC
October 2015

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.

Invest New Drugs 2015 Aug 7;33(4):890-4. Epub 2015 May 7.

Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0244-4DOI Listing
August 2015

Seven novel probe systems for real-time PCR provide absolute single-base discrimination, higher signaling, and generic components.

J Mol Diagn 2014 Nov;16(6):627-38

GeneTAG Technology, Inc., Atlanta, Georgia; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.06.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210465PMC
November 2014

A role for H/ACA and C/D small nucleolar RNAs in viral replication.

Mol Biotechnol 2014 May;56(5):429-37

Zirus, Inc., 1384 Buford Business Boulevard, Suite 700, Buford, GA, 30518, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12033-013-9730-0
Publisher Site
http://dx.doi.org/10.1007/s12033-013-9730-0DOI Listing
May 2014

Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain.

Virology 2014 Apr 22;454-455:60-6. Epub 2014 Feb 22.

Department Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2014.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018752PMC
April 2014

The dual role of tetraspanin CD63 in HIV-1 replication.

Virol J 2014 Feb 8;11:23. Epub 2014 Feb 8.

Department of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of Texas Medical Branch, Galveston, Texas 77555-0435, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-11-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944621PMC
February 2014

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial.

J Cancer 2013 22;4(7):577-84. Epub 2013 Aug 22.

1. Departments of Breast Medical Oncology (NKI, JLM), Melanoma Medical Oncology (DZ), and Surgical Oncology (EAM), The University of Texas MD Anderson Cancer Center, Houston, TX;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.7028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753533PMC
August 2013

Host factors mediating HIV-1 replication.

Virus Res 2011 Nov 18;161(2):101-14. Epub 2011 Aug 18.

Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston, Texas 77555-0435, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01681702110028
Publisher Site
http://dx.doi.org/10.1016/j.virusres.2011.08.001DOI Listing
November 2011

Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.

Expert Rev Vaccines 2011 Jun;10(6):755-74

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/erv.11.59
Publisher Site
http://dx.doi.org/10.1586/erv.11.59DOI Listing
June 2011

A functional role for ADAM10 in human immunodeficiency virus type-1 replication.

Retrovirology 2011 May 11;8:32. Epub 2011 May 11.

Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-4690-8-32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118345PMC
May 2011

A post-entry role for CD63 in early HIV-1 replication.

Virology 2011 Apr 26;412(2):315-24. Epub 2011 Feb 26.

Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555-0435, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2011.01.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060945PMC
April 2011

A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.

Cancer 2010 May;116(10):2301-6

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25042DOI Listing
May 2010

Therapeutic breast cancer vaccines: a new strategy for early-stage disease.

BioDrugs 2009 ;23(5):277-87

Department of Medicine, San Antonio Military Medical Center, San Antonio, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11313490-000000000-00000DOI Listing
November 2009

CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37).

Expert Opin Biol Ther 2009 Jan;9(1):71-8

University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590802614538DOI Listing
January 2009

Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.

J Clin Oncol 2008 Jul;26(20):3426-33

Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Dr, Fort Sam Houston, TX, 78234, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.7842DOI Listing
July 2008

Relationship between epidemiologic risk factors and breast cancer recurrence.

J Clin Oncol 2007 Oct 4;25(28):4438-44. Epub 2007 Sep 4.

Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.10.6815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559726PMC
October 2007

Rab 5 is required for the cellular entry of dengue and West Nile viruses.

J Virol 2007 May 14;81(9):4881-5. Epub 2007 Feb 14.

Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, The Anlyan Center for Medical Research and Education, 300 Cedar Street, New Haven, CT 06520-8031, USA.

View Article

Download full-text PDF

Source
http://jvi.asm.org/content/81/9/4881.full.pdf
Web Search
http://jvi.asm.org/content/early/2007/02/14/JVI.02210-06.ful
Web Search
http://jvi.asm.org/cgi/doi/10.1128/JVI.02210-06
Publisher Site
http://dx.doi.org/10.1128/JVI.02210-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1900185PMC
May 2007

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer.

Cancer Immunol Immunother 2004 Jun 22;53(6):490-6. Epub 2004 Jan 22.

M.D. Anderson Cancer Center, 1525 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-003-0463-yDOI Listing
June 2004

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.

Cancer 2004 May;100(10):2195-200

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20252DOI Listing
May 2004

Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues.

Cancer Treat Rev 2004 Apr;30(2):165-72

Department of Nuclear Medicine, UCLA Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2003.07.006DOI Listing
April 2004

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.

J Biol Chem 2003 Nov 4;278(47):47136-44. Epub 2003 Sep 4.

J. G. Brown Modeling Facility, 323 Brown Cancer Center, Department of Medicine, University of Louisville, 529 S. Jackson Street, Louisville, KY 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M307850200DOI Listing
November 2003

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

J Clin Oncol 2003 Sep;21(18):3454-61

Box 424, Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.02.114DOI Listing
September 2003

Clinical studies of vaccines targeting breast cancer.

Clin Cancer Res 2003 Aug;9(9):3222-34

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
August 2003

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma.

J Clin Oncol 2003 Apr;21(7):1263-70

Division of Internal Medicine and Hematology and the Department of Radiology, Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.08.043DOI Listing
April 2003

Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.

Arch Ophthalmol 2002 Sep;120(9):1225-7

Ophthalmology Section, Department of Plastic Surgery, Box 443, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
September 2002

Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.

J Interferon Cytokine Res 2002 May;22(5):583-92

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/10799900252982061DOI Listing
May 2002

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

Cancer Invest 2002 ;20(1):29-37

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-120000363DOI Listing
March 2002

Role of CD4 hinge region in GP120 utilization by immunoglobulin domain 1.

Biochem Biophys Res Commun 2002 Mar;292(2):449-55

Henry Vogt Cancer Research Center, University of Louisville, Louisville, Kentucky 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.2002.6677DOI Listing
March 2002